IBD Patients in Pilot Study to Use Digital Watch to Track Symptoms, Disease Triggers

IBD Patients in Pilot Study to Use Digital Watch to Track Symptoms, Disease Triggers
Takeda Pharmaceuticals U.S.A. has announced the launch of a pilot digital technology program that consists of a watch specially designed to help patients and physicians manage inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis (UC). The digital technology program, iBData, is designed to cross healthcare and digital technologies. Digital approaches are being used in new platforms across many sectors of healthcare to advance such steps as diagnostics, disease progression, and treatment response. “iBData leverages the remarkable capabilities available today when wearable technologies and medicine converge, in an effort to help overcome these challenges,” Stephanie Brown, vice president and head of Specialty Business Unit at Takeda, said in a press release. “This innovative pilot program will explore new ways to transform care by generating novel insights into the patient experience that physicians can directly utilize.” In partnership with Texas Digestive disease Consultants (TDDC) and Vanderbilt University Medical Center (VUMC), the pilot program will allow IBD patients to track their symptoms and lifestyle using wearable watch technology. The technology will allow physicians and patients to have an o
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *